Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Other financing activities (2023 - 2025)

Historic Other financing activities for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $270000.0.

  • CG Oncology's Other financing activities changed N/A to $270000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$277000.0, marking a year-over-year increase of 9578.71%. This contributed to the annual value of -$3.4 million for FY2024, which is 8.77% down from last year.
  • According to the latest figures from Q3 2025, CG Oncology's Other financing activities is $270000.0.
  • CG Oncology's 5-year Other financing activities high stood at $270000.0 for Q3 2025, and its period low was -$3.4 million during Q1 2024.
  • Over the past 3 years, CG Oncology's median Other financing activities value was -$273500.0 (recorded in 2025), while the average stood at -$1.1 million.
  • Over the last 5 years, CG Oncology's Other financing activities had its largest YoY gain of 9315.03% in 2025, and its largest YoY loss of 75135.14% in 2025.
  • CG Oncology's Other financing activities (Quarter) stood at -$3.2 million in 2023, then surged by 98.83% to -$37000.0 in 2024, then surged by 829.73% to $270000.0 in 2025.
  • Its last three reported values are $270000.0 in Q3 2025, -$315000.0 for Q2 2025, and -$232000.0 during Q1 2025.